This segment focuses on the research, development, manufacturing, and commercialization of heparin sodium and low molecular weight heparin (LMWH) products. Research and development activities include process optimization, formulation development, and the exploration of new heparin derivatives. The company utilizes advanced purification and manufacturing technologies to ensure product quality and efficacy. The primary therapeutic area is anticoagulation, addressing conditions such as deep vein thrombosis, pulmonary embolism, and other thromboembolic disorders. The patient impact is significant, as these drugs are life-saving treatments. Market positioning is strong in China, with growing exports to Europe and America. Competitive advantages include established manufacturing capabilities, regulatory approvals, and a focus on quality. Future opportunities include expanding the product portfolio and entering new markets. Regulatory and clinical aspects involve adherence to stringent GMP standards and clinical trials to demonstrate safety and efficacy. Partnerships with pharmaceutical companies are key for distribution and market access.

This segment concentrates on the production and sales of Active Pharmaceutical Ingredients (APIs), specifically heparin sodium and its derivatives. The company employs advanced extraction, purification, and synthesis methodologies to produce high-quality APIs. The therapeutic applications of these APIs are primarily in anticoagulation and related cardiovascular treatments. The segment's focus is on providing essential raw materials to pharmaceutical companies globally. The patient impact is indirect but crucial, as these APIs are the building blocks for life-saving medications. Market positioning is based on the company's manufacturing expertise and regulatory compliance. Competitive advantages include established supply chains and a focus on quality control. Future opportunities involve expanding the API product line and exploring new applications. Regulatory aspects include compliance with international standards and obtaining necessary certifications. Partnerships with pharmaceutical companies are essential for API sales and distribution.